Benjamin Duong, PharmD

Clinical Pharmacogenomics Service Manager

Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

Biography

Benjamin Duong is the Clinical Pharmacogenomics Service Manager under Nemours Precision Medicine Program at Nemours Children's Health (NCH) in Wilmington, DE. He leads of the implementation of the Nemours Clinical Pharmacogenomics Service across the NCH enterprise. His Service includes developing an in-house pharmacogenomic panel with the Molecular Diagnostic Laboratory, integrating pharmacogenetic clinical decision support into the electronic medical records, providing clinical recommendations, and educating patients and health care professionals regarding pharmacogenomics. He has collaborated with multiple institutions within the NIH-funded Implementing Genomics in Practice (IGNITE) Network and co-authored multiple papers regarding the implementation of pharmacogenomics.

Education

  • PGY2 - Clinical Pharmacogenomics - University of Florida College of Pharmacy, Pharmacotherapy and Translational Research, 2018
  • PharmD - University of Florida College of Pharmacy, 2016

  • From bench to bedside: a spotlight on pharmacogenomics at Nemours Children's Health.; Pharmacogenomics; (2025).

    View Full Publication
  • Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health System.; The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG; (2025).

    View Full Publication
  • Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment.; Pediatric research; (2025).

    View Full Publication
  • Rationale and design for a pragmatic randomized trial to assess gene‐based prescribing for SSRIs in the treatment of depression; Clinical and Translational Science; (2024).

    View Full Publication
  • The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.; Pharmacogenetics and genomics; (2024).

    View Full Publication
  • Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution; Clinical and Translational Science; (2023).

    View Full Publication
  • Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.; Implementation science communications; (2022).

    View Full Publication
  • Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.; Genetics in medicine : official journal of the American College of Medical Genetics; (2021).

    View Full Publication
  • Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics.; Clinical pharmacology and therapeutics; (2021).

    View Full Publication
  • Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.; Clinical and translational science; (2021).

    View Full Publication
  • Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.; Genetics in medicine : official journal of the American College of Medical Genetics; (2021).

    View Full Publication
  • Realities of Pharmacogenomic and Minimizing Misconceptions and Medication Misadventures.; Delaware journal of public health; (2021).

    View Full Publication
  • β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery.; Clinical and translational science; (2021).

    View Full Publication
  • Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network

    ; Pharmacogenomics and Personalized Medicine; (2020).

    View Full Publication
  • A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications.; Clinical pharmacology and therapeutics; (2020).

    View Full Publication
  • Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic; Journal of Clinical Medicine; (2020).

    View Full Publication
  • A stepwise approach to implementing pharmacogenetic testing in the primary care setting.; Pharmacogenomics; (2019).

    View Full Publication
  • CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.; Genetics in medicine : official journal of the American College of Medical Genetics; (2019).

    View Full Publication
  • Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.; Genetics in medicine : official journal of the American College of Medical Genetics; (2019).

    View Full Publication
  • Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.; Clinical and translational science; (2018).

    View Full Publication